SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-24-043474
Filing Date
2024-02-23
Accepted
2024-02-23 06:25:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d790400dsc14d9.htm SC 14D9 521169
2 EX-99.(E)(2) d790400dex99e2.htm EX-99.(E)(2) 22297
3 EX-99.(E)(12) d790400dex99e12.htm EX-99.(E)(12) 36065
4 EX-99.(E)(18) d790400dex99e18.htm EX-99.(E)(18) 21266
5 GRAPHIC g790400g25n25.jpg GRAPHIC 28378
  Complete submission text file 0001193125-24-043474.txt   638857
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filed by) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-87950 | Film No.: 24667183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)